Anti-amyloid therapies: Practical insights and first experiences

Dementia Update - Clinical Series with Aurélien Lathuilière

A webinar by Dr. Aurélien Lathuilière, University Hospital of Geneva

The potential approval of anti-amyloid monoclonal antibody therapies for Alzheimer’s disease in Switzerland represents a major milestone in dementia care, but it also brings new challenges for healthcare systems. In this webinar, , neurologist at the Memory Center of Geneva University Hospitals, will share practical strategies for preparing healthcare infrastructures. He will illustrate how these therapies can be integrated into existing care structures and will discuss potential bottlenecks. In addition, he will present firsthand early experiences with the use of anti-amyloid monoclonal therapies in people with Alzheimer’s disease.

The webinar is hosted by (Inselspital Bern / Neuro Im Zentrum, St. Gallen) and offers a platform for shared learning and discussion, enabling participants to exchange insights and experiences.

Event details:

  • Date: 15.01.2026
  • Time: 12:00
  • Duration: 50 minutes (includes Q&A)
  • Location: Online (link to be provided upon registration)
  • Costs: Free of charge

Credits

  • Schweizerische Vereinigung für Neuropsychologie (SVNP): 1 credit
  • Schweizerische Fachgesellschaft für Geriatrie (SFGG): tbd
  • Schweizerische Neurologische Gesellschaft (SNG): tbd
  • Schweizerische Gesellschaft für Alterspsychiatrie und Alterspsychotherapie (SGAP-SPPA): 1 credit

Secure your spot

Fill out the registration form below and you will receive a link to access the webinar.

About the speaker

Dr. Aurélien Lathuilière is featured on our community platform’s expert list. Visit his profile to explore his research interests, ongoing projects, publications, and potential collaboration opportunities.

Close up front facing picture of Aurélien Lathulière

swiss memory clinics logo

Dementia Update - Clinical Series

Developed with the Swiss Memory Clinics for clinicians and healthcare professionals working in dementia care, each session addresses a key clinical topic and includes an interactive discussion with Q&A. The series promotes knowledge exchange across and within clinical disciplines and is hosted by a representative of the Swiss Memory Clinics.